Page
%P
-
Article
The effect of etanercept on Graves' ophthalmopathy: a pilot study
To assess the effect of etanercept, an antitumour necrosis factor (anti-TNF) drug, on clinical signs in Graves' ophthalmopathy (GO).
-
Article
Open AccessMast cells are major contributors to the pathophysiology of Graves’ Ophthalmopathy (GO)
-
Article
Open AccessThe neonatal Fc receptor is expressed by human lymphocytes
-
Article
Open AccessEfficacy of adalimumab in sarcoidosis
-
Article
Open AccessInflammatory T-lymphocyte proliferation in morbid obesity